ScinoPharm Taiwan Ltd
TWSE:1789
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
ScinoPharm Taiwan Ltd
TWSE:1789
|
TW |
|
CMO Group PLC
LSE:CMO
|
UK |
Intrinsic Value
The intrinsic value for
ScinoPharm Taiwan Ltd (1789) under the Base Case is 16.63 TWD.
Compared with the current market price of 19.1 TWD, the stock appears
Overvalued by 13% .
Do our valuations actually work? See backtest results .
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for ScinoPharm Taiwan Ltd.
Fundamental Analysis
Revenue & Expenses Breakdown
ScinoPharm Taiwan Ltd
Earnings Waterfall
ScinoPharm Taiwan Ltd
The intrinsic value for
ScinoPharm Taiwan Ltd (1789) under the Base Case is 16.63 TWD.
Compared with the current market price of 19.1 TWD, the stock appears Overvalued by 13% .